Pseudomonas aeruginosa is responsible for a substantial fraction of hospita
l infections. Twenty-Eve European university hospitals submitted a total of
1411 Pseudomonas aeruginosa isolates for susceptibility testing during 199
7 and 1998. The isolates showed highest susceptibility to amikacin (87.5%),
meropenem (87.3%) and piperacillin/tazobactam (86.8%). Susceptibility to c
iprofloxacin was 73.2%. There was no clear geographical distribution of res
istance, although isolates from northwestern Europe tended to be more susce
ptible than those from southeastern Europe. Isolates that were resistant to
one class of antibiotics were also often resistant to at least one other c
lass of antibiotics. Imipenem-resistant isolates were generally not clonall
y related.